BioVie Forms Advisory Board for Bezisterim in Long COVID
Tuesday, 4 June 2024, 09:12
BioVie Forms Advisory Board for Bezisterim in Long COVID
BioVie has taken a crucial step in the battle against Long COVID by introducing an Advisory Board for Bezisterim. This strategic initiative is tailored to tackle the enduring impacts of COVID-19 on individuals' health and well-being.
Key Points:
- BioVie announced the formation of an Advisory Board for Bezisterim to address Long COVID.
- Specialized Support: The board aims to provide specialized assistance for those suffering long-term COVID effects.
- Research and Strategies: BioVie's focus is on driving research and strategies for Long COVID treatments.
- Significant Progress: This move represents a notable advancement in post-COVID symptom therapies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.